Contact William Graf, MD
860.837.7500

Request An Appointment

William Graf, MD

Loading...
Practice Name Connecticut Children's Specialty Group
Education

Education:
University of Wisconsin-Madison, 1975
Ludwig-Maximilian-Universitat, Munich, Germany
, 1979
MD, Freie Universitat-Berlin, West Berlin, Germany, 1983
Residency:
Pediatrics, New York University/Bellevue Hospital, New York, NY, 1983-1984
Pediatrics, Albert Einstein College of Medicine, Bronx, NY, 1984-1986
Neurology/Child Neurology, University of Washington/Seattle Children’s Hospital, 1988-1991
Fellowship:
Neurodevelopmental Disabilities, New Medical College, Valhalla, NY, 1986-1988

Board Certifications
  • Pediatrics
  • Neurology with Special Competence in Child Neurology
  • Neurodevelopment Disabilities
  • Epilepsy
  • Faculty Appointment

    Visiting Professor of Pediatrics, University of Connecticut School of Medicine

    Clinical Expertise

    Dr. Graf strives to find the best diagnostic approaches to complex neurodevelopmental disorders and appropriate medical care for families whose children have neurodevelopmental disabilities. His clinical research interests are in neurogenetics, neurodevelopmental disorders, and bioethics. Dr. Graf serves on the Editorial Board of the Journal of Child Neurology. He is Chair of the Ethics Committee of the Child Neurology Society and an active member of the Ethics, Law, and Humanities Committee of the American Academy of Neurology.

    Selected Publications
    • Graf WD, Li P. Professional Practice Guidelines and the Importance of Early Diagnosis for Developmental Disorders. In: Pediatric Genetic Testing for Developmental Disorders: Chromosomal Microarray Analysis (CMA). John Wiley & Sons, Inc. 2016.

    • Graf WD. Communicating Concerns about Early Signs of Autism to Parents. AMA Journal of Ethics 2015; 17:310-317.

    • Graf WD, Singh I. Can guidelines help reduce the medicalization of early childhood? J Pediatr 2015;166(6):1344-6.

    • Graf WD, Yu S. Cerebral Malformations. In: Rosenberg’s Molecular and Genetic Basis of Neurological and Psychiatric Disease, Fifth Edition. © 2014 Elsevier B.V. 2015.

    • Graf WD, Nagel SK, Epstein LG, Miller G, Nass R, Larriviere D. Pediatric neuroenhancement: ethical, legal, social, and neurodevelopmental implications. Neurology 2013;80:1251-60.

    • Graf WD, Miller G, Nagel SK. Addressing the problem of ADHD medication as neuroenhancements. Expert Reviews Neurotherapeutics. 2014;5: 569-81.

    • Nagel SK, Graf WD. Enhancement in children and adolescents – scrutinizing effects beyond cognition. Am J Bioethics (AJOB) Neuroscience 2013;4:22-4.

    • Le Pichon J-B, Yu S, Kibiryeva N, Graf WD, Bittel DC. Genome wide gene expression in a patient with 15q13.3 homozygous microdeletion syndrome. Eur J Hum Genet. 2013;21(10):1093-9.

    • Graf WD, Epstein LG. No PEDs in Pediatrics. Pediatric Neurology. 2014;50:288-289.

    • Yu S, Graf WD, Shprintzen RJ. Genomic disorders on chromosome 22. Curr Opin Pediatr 2012, 24:665-71) DOI:10.1097/MOP.0b013e328358acd0

    Additional Information

    Clinical Interests:

    • Neurodevelopmental disorders
    • Pediatric Epilepsy
    • Neurogenetics
    • Neuroethics
    Patient Feedback The Patient Rating score is an average of all responses to physician related questions on our nationally-recognized Patient Satisfaction Survey . Responses are measured on a scale of 1 to 5, with 5 being the best score. Comments also are gathered from our Patient Satisfaction Survey and displayed in their entirety. Patients are de-identified for confidentiality and patient privacy.

    QUESTION BREAKDOWN

    RATINGS DISTRIBUTION AND COMMENTS


    Back to Top
    Searching Animation
    Searching